SMBC · Southern Missouri Bancorp, Inc. · Insider Trading

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/18/26. Each remaining installment vests annually thereafter.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/8/25. Each remaining installment vests annually thereafter.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 9/19/24. Each remaining installment vests annually thereafter.

Represents the weighted average price per share. The shares were sold at prices ranging from $73.19 to $73.365 with a weighted average purchase price of 73.29 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U. S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer.

Represents the weighted average price per share. The shares were sold at prices ranging from $72.19 to $73.175 with a weighted average purchase price of 72.63 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U. S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer.

Represents the weighted average price per share. The shares were sold at prices ranging from $72.19 to $73.175 with a weighted average purchase price of 73.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U. S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 1/16/19. Each remaining installment vests annually thereafter.

On July 29, 2026, the Reporting Person exercised employee stock options to purchase an aggregate of 4,000 shares of the Issuer's common stock, consisting of options to purchase 2,000 shares at an exercise price of $37.31 per share and options to purchase 2,000 shares at an exercise price of $34.35 per share. The aggregate exercise price of $143,320 was paid through the delivery to the Issuer of 1,830 shares of common stock previously owned by the Reporting Person having an aggregate fair market value of $143,307, together with a cash payment of $13. The surrendered shares are reported in Table I as a disposition.

On July 29, 2026, the Reporting Person exercised employee stock options to purchase an aggregate of 4,000 shares of the Issuer's common stock, consisting of options to purchase 2,000 shares at an exercise price of $37.31 per share and options to purchase 2,000 shares at an exercise price of $34.35 per share. The aggregate exercise price of $143,320 was paid through the delivery to the Issuer of 1,830 shares of common stock previously owned by the Reporting Person having an aggregate fair market value of $143,307, together with a cash payment of $13. The surrendered shares are reported in Table I as a disposition.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 1/4/20. Each remaining installment vests annually thereafter.

On July 29, 2026, the Reporting Person exercised employee stock options to purchase an aggregate of 4,000 shares of the Issuer's common stock, consisting of options to purchase 2,000 shares at an exercise price of $37.31 per share and options to purchase 2,000 shares at an exercise price of $34.35 per share. The aggregate exercise price of $143,320 was paid through the delivery to the Issuer of 1,830 shares of common stock previously owned by the Reporting Person having an aggregate fair market value of $143,307, together with a cash payment of $13. The surrendered shares are reported in Table I as a disposition.

Represents the weighted average price per share. The shares were sold at prices ranging from $69.65 to $69.93. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U. S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer.

The reporting person exercised a stock option to purchase 2,000 shares of common stock at an exercise price of $37.40 per share.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/18/21. Each remaining installment vests annually thereafter.

The reporting person previously reported these shares as indirectly owned as trustee of her family trust pursuant to inheritance laws. Upon distribution of the estate's assets, 10,000 shares were distributed to the reporting person and 10,000 shares were distributed to an unaffiliated beneficiary. These transactions are exempt from section 16(b).

The reporting person previously reported these shares as indirectly owned as trustee of her family trust pursuant to inheritance laws. Upon distribution of the estate's assets, 10,000 shares were distributed to the reporting person and 10,000 shares were distributed to an unaffiliated beneficiary. These transactions are exempt from section 16(b).

The reported shares were acquired pursuant to the distribution of the Estate of Pasty Hecker. This transaction is exempt from Section 16(b).

The options become exercisable in 20% installments over a five-year period with the first installment vesting on 1/4/20. Each remaining installment vests annually thereafter.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/24/27. Each remaining installment vests annually thereafter.

The shares are scheduled to vest over a five-year period beginning February 9, 2027, with up to 20% of the shares vesting on that date and on each of the next four anniversaries of that date based on the extent to which the Company's annualized return on average assets over the 12 calendar quarters ending immediately prior to the applicable vesting date exceeds a threshold level.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

The shares are scheduled to vest over a five-year period beginning February 9, 2027, with up to 20% of the shares vesting on that date and on each of the next four anniversaries of that date based on the extent to which the Company's annualized return on average assets over the 12 calendar quarters ending immediately prior to the applicable vesting date exceeds a threshold level.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/24/27. Each remaining installment vests annually thereafter.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/24/27. Each remaining installment vests annually thereafter.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/24/27. Each remaining installment vests annually thereafter.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

The shares are scheduled to vest over a five-year period beginning February 9, 2027, with up to 20% of the shares vesting on that date and on each of the next four anniversaries of that date based on the extent to which the Company's annualized return on average assets over the 12 calendar quarters ending immediately prior to the applicable vesting date exceeds a threshold level.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

The shares are scheduled to vest over a five-year period beginning February 9, 2027, with up to 20% of the shares vesting on that date and on each of the next four anniversaries of that date based on the extent to which the Company's annualized return on average assets over the 12 calendar quarters ending immediately prior to the applicable vesting date exceeds a threshold level.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.

The shares are scheduled to vest over a five-year period beginning February 9, 2027 with up to 20% of the shares vesting on that date and on each of the next four anniversaries of that date based on the extent to which the Company's annualized return on average assets over the 12 calendar quarters ending immediately prior to the applicable vesting date exceeds a threshold level.

The options become exercisable in 20% installments over a five-year period with the first installment vesting on 2/24/27. Each remaining installment vests annually thereafter.

The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/24/27. Each remaining installment vests annually thereafter.

Grant of restricted stock. The shares are scheduled to vest over a five-year period beginning February 9, 2027, with 20% of the shares vesting on that date and on each of the next four anniversaries of that date.